DNA Fab Keeps Getting More Fab
DNA Fabrication Keeps Improving, Thanks to Innovations in Biosensors, DNA Nanoswitches, and Microfluidic Chips
Reducing the Need for Clinical Bioequivalence Endpoint Studies
Raman Spectroscopy and MDRS Enable Determination of the Size and Shape of Specific Components Within a Multicomponent Blend
HCV Drug Therapy and the DNA Base Excision Repair System
The Influence of New Anti-HCV Therapy on the DNA Base Excision Repair System of Peripheral Blood Mononuclear Cells
The Prodrug Opportunity: Making Good Drugs Better
Elegance in Chemistry, Product Development, and Marketability
For full access to this article login to GEN Select now.
Targeting PARPs with Novel Drugs: Back to the Laboratory?
Exploiting synthetic lethality for cancer therapy.
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.